Table 1. Summary results of TB screening by strategy at the icddr,b SEM screening centres (2014−2017).
| Factors | ||||||
|---|---|---|---|---|---|---|
| Total | Private Providers | DOTS/ BMUs | Walk-ins | Contact investigation | Pharmacies | |
| N | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Attendees served at the SCs | 64031 | 51129 (80) | 3859 (6) | 7424 (12) | 660 (1) | 959 (1) |
| Adults (≥15) | 61192 | 48893 (80) | 3687 (6) | 7104 (12) | 598 (1) | 910 (1) |
| Children (<15) | 2839 | 2236 (79) | 172 (6) | 320 (11) | 62 (2) | 49 (2) |
| Screening service | ||||||
| Attendees came for TB screening | 57580 | 45778 (80) | 3421 (6) | 6856 (12) | 605 (1) | 920 (2) |
| Presumptive cases received a CXR | 54125 | 42465 (78) | 3388 (6) | 6764 (12) | 571 (1) | 937 (2) |
| Presumptive cases provided sputum | 53730 | 42494 (79) | 3250 (6) | 6537 (12) | 567 (1) | 882 (2) |
| First time Failed Xpert tests | 1350 | 1064 (79) | 110 (8) | 146 (11) | 12 (1) | 18 (1) |
| TB patients diagnosed by Xpert test | 7695 | 6277 (82) | 518 (7) | 737 (10) | 69 (1) | 94 (1) |
| RIFa Sensitive | 7247 | 5928 (82) | 481 (7) | 682 (9) | 67 (1) | 89 (1) |
| RIF Indeterminate | 109 | 82 (75) | 10 (9) | 15 (14) | 1 (1) | 1 (1) |
| RIF Resistant | 339 | 267 (79) | 27 (8) | 40 (12) | 1 (0) | 4 (1) |
| TB patients diagnosed clinically | 1455 | 1195 (82) | 95 (7) | 137 (9) | 11 (1) | 17 (1) |
| Commercial service | ||||||
| TB patients detected by Xpert test | 183 | 183 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| RIF Sensitive | 170 | 170 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| RIF Indeterminate | 3 | 3 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| RIF Resistant | 10 | 10 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| TB patients detected by AFBb & Culture | 188 | 150 (80) | 10 (5) | 23 (12) | 2 (1) | 3 (2) |
| EP-TBc patients detected | 695 | 603 (87) | 43 (6) | 42 (6) | 3 (0) | 4 (1) |
| TB patients diagnosed clinically | 72 | 72 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Total TB cases (all forms) identified | 10288 | 8480 (82) | 666 (6) | 939 (9) | 85 (1) | 118 (1) |
| Adults (≥15) | 9982 | 8217 (82) | 648 (6) | 917 (9) | 84 (1) | 116 (1) |
| Children (<15) | 306 | 263 (86) | 18 (6) | 22 (7) | 1 (0) | 2 (1) |
| Treatment status | ||||||
| Patients died before treatment initiation | 134 | 118 (88) | 6 (4) | 8 (6) | 0 (0) | 2 (1) |
| Patients (all forms) started First-line TXd | 8077 | 6711 (83) | 480 (6) | 736 (9) | 64 (1) | 86 (1) |
| DOTS facilities | 7039 | 5826 (83) | 426 (6) | 654 (9) | 54 (1) | 79 (1) |
| Private sector | 1038 | 884 (85) | 54 (5) | 83 (8) | 10 (1) | 7 (1) |
| First line pre-treatment loss to follow up | 1728 | 1374 (80) | 153 (9) | 155 (9) | 20 (1) | 26 (2) |
| RRe Patients started second-line TX | 254 | 206 (81) | 21 (8) | 26 (10) | 0 (0) | 1 (0) |
| RR Patients started first-line TX | 7 | 4 (57) | 1 (14) | 2 (29) | 0 (0) | 0 (0) |
| Second line pre-treatment loss to follow up | 88 | 67 (76) | 5 (6) | 12 (14) | 1 (1) | 3 (3) |
a RIF (resistance to Rifampicin),
bAFB (acid fast bacilli),
cEP-TB (extra-pulmonary TB),
dTX (treatment),
eRR (rifampicin-resistant)